Partnerships between philanthropy, government and industry are needed to advance drug discovery for neurodegenerative diseases.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Current Alzheimer Research

• Publication date

  2006-06-30

• Fields of study

  Medicine, Business

• Identifiers
  DOI 10.2174/156720506777632853PMID 16842090
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Alzheimer's disease drug development pipeline: 2017

  2017cites this paper
• Alzheimer's disease drug development: translational neuroscience strategies

  2013cites this paper
• Novel approaches to incorporating pharmacoeconomic studies into phase III clinical trials for Alzheimer's disease

  2010cites this paper
• Regenerative potential of allopregnanolone.

  2008cites this paper
• Drug discovery and the prevention of Alzheimer's disease

  2008cites this paper
• Drug discovery for Alzheimer's disease: filling the pipeline.

  2007cites this paper